Lucas Ward
Stock Analyst at Ascendiant
(0.04)
# 4,867
Out of 5,118 analysts
57
Total ratings
15%
Success rate
-58.3%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VVOS Vivos Therapeutics | Reiterated: Buy | $3 → $3.1 | $0.0937 | +3,208.43% | 12 | Jun 4, 2026 | |
| ACON Aclarion | Reiterated: Buy | $7 → $7.5 | $1.66 | +351.81% | 8 | May 28, 2026 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterated: Buy | $4.2 → $3.7 | $0.5949 | +521.95% | 10 | May 22, 2026 | |
| LIQT LiqTech International | Reiterated: Buy | $4.3 → $4.4 | $0.294 | +1,396.60% | 10 | May 20, 2026 | |
| HSCS HeartSciences | Reiterated: Buy | $9.2 → $8 | $2.83 | +182.69% | 12 | Mar 23, 2026 | |
| VMAR Vision Marine Technologies | Reiterated: Buy | $30 → $10 | $5.14 | n/a | 5 | Apr 30, 2025 |
Vivos Therapeutics
Jun 4, 2026
Reiterated: Buy
Price Target: $3 → $3.1
Current: $0.0937
Upside: +3,208.43%
Aclarion
May 28, 2026
Reiterated: Buy
Price Target: $7 → $7.5
Current: $1.66
Upside: +351.81%
60 Degrees Pharmaceuticals
May 22, 2026
Reiterated: Buy
Price Target: $4.2 → $3.7
Current: $0.5949
Upside: +521.95%
LiqTech International
May 20, 2026
Reiterated: Buy
Price Target: $4.3 → $4.4
Current: $0.294
Upside: +1,396.60%
HeartSciences
Mar 23, 2026
Reiterated: Buy
Price Target: $9.2 → $8
Current: $2.83
Upside: +182.69%
Vision Marine Technologies
Apr 30, 2025
Reiterated: Buy
Price Target: $30 → $10
Current: $5.14
Upside: n/a